NCSD

Graphic for episode 1010 of Public Health On Call podcast, titled Centering Pleasure in Sexual Health. Adorned with hearts and condom packets, this slide reads “Please as Prevention” and includes logos for Public Health On Call podcast and the National Coalition of STD Directors.

A pleasure-centered approach to STI prevention starts with a focus on what feels good in order to promote honest communication and holistic sex education.

Listen to the latest episode from Public Health On Call and @ncsddc.bsky.social Real Talk

🎧 podcast.publichealth.jhu.edu/1010-centeri...

Promo graphic for episode 1010 of Public Health On Call, titled Centering Pleasure in Sexual Health. Additional text reads: An approach to sexual health that includes frank discussions of what feels good could yield better health outcomes.

An approach to sexual health that includes frank discussions of what feels good could yield better health outcomes.

In today's episode—made with @ncsddc.bsky.social—sexual health educator Joshua O’Neal talks about the value of starting conversation with enjoyment.

🎧 tinyurl.com/ytw4jze9

Mississippi experiences explosive growth in maternal syphilis

Mississippi experiences explosive growth in maternal syphilis. Read more: www.cidrap.umn.edu/sexually-tra...

FDA Approves Zoliflodacin for Uncomplicated Urogenital Gonorrhea | Contagion Live The antibiotic's approval was based from phase 3 results demonstrating noninferiority to a combination therapy.

The FDA recently approved a second new drug, zoliflodacin (Nuzolvence), for the treatment of uncomplicated urogenital gonorrhea. Read more: www.contagionlive.com/view/fda-app...

FDA approves first new gonorrhea drug in decades FDA approves new drug to treat gonorrhea, which is notorious for developing resistance to medicines

FDA approves new drug to treat gonorrhea, which is notorious for developing resistance to medicines
www.statnews.com/2025/12/11/f...

US FDA expands use of GSK's Blujepa as treatment for gonorrhea The U.S. Food and Drug Administration said on Thursday it has expanded the use of GSK's Blujepa as an oral treatment for gonorrhea, a common sexually transmitted infection.

US FDA expands use of GSK's Blujepa as treatment for gonorrhea. Read more: www.reuters.com/business/hea...

New mpox strain identified in England It's a mix of two major types of the virus, and has been found in someone who recently returned from Asia.

A new strain of mpox has been detected in a person in England, say UK health officials. Read more: www.bbc.com/news/article...

WHO warns of rising, worrisome levels of drug-resistant gonorrhea

Data from a new surveillance report show rising resistance to ceftriaxone and cefixime, the two antibiotics currently recommended for gonorrhea treatment.

www.cidrap.umn.edu/g...

Access Uncertain for New Injectable PrEP as the Affordable Care Act’s (ACA) Open Enrollment Begins | KFF This analysis examines access to, and consumers ability to find information on, a new twice annual long-acting PrEP drug during the first ACA open enrollment period since its approval. Despite the dru...

Access uncertain for new injectable PrEP as the Affordable Care Act's (ACA) open enrollment begins. Read more: www.kff.org/hiv-aids/acc...

Antibody from Tanzanian woman suppresses almost all tested HIV variants including resistant viruses in pre-clinical study An antibody from a Tanzanian woman discovered during screening for anti-HIV antibodies shows a strong therapeutic potential in a preclinical study. Named 04_A06, it neutralised (blocked) 97.3% of over...

Antibody from Tanzanian woman suppresses almost all tested HIV variants including resistant viruses in pre-clinical study. Read more: www.aidsmap.com/news/nov-202...

Got Persistent BV? This New Treatment Approach May Help It involves a little teamwork.

New guidelines suggest treating male sexual partners to try to lower the risk of patients passing BV back and forth to each other. Read more: www.self.com/story/bacter...

Los Angeles County documents 2nd case of locally acquired clade 1 mpox The county announced the detection yesterday, and it involves an adult with no recent travel to mpox-endemic areas.

Los Angeles County documents second case of locally acquired clade 1 mpox. Read more: www.cidrap.umn.edu/mpox/los-ang...

Shutdown Halts Some Health Services as Political Risks Test Parties’ Resolve - KFF Health News Congressional Democrats and Republicans are at an impasse in negotiations. Which side will blink first?

Ramifications from a shutdown on public health systems and programs will be felt far beyond Washington, halting almost all of the federal government’s nonessential functions, including many related to public health.

kffhealthnews.org/news/article...

Sexually Transmitted Infections Surveillance, 2024 (Provisional) The most recent national data for reportable STIs: chlamydia, syphilis, gonorrhea.

The 2024 STI Surveillance Data was released today by the CDC!
Cases of chlamydia, gonorrhea, and primary & secondary syphilis declined from the year prior, but are all at higher levels than they were ten years ago, signaling there's still progress to be made. Read more: www.cdc.gov/sti-statisti...

@ncsddc.bsky.social is implementing a coordinated national strategy to strengthen the disease intervention (DI) workforce by developing high-quality, standardized training and continuing education via ASPPH’s UniversiDI to the US disease intervention (DI) workforce.

One dose of antibiotic treats early syphilis as well as three doses NIH-funded clinical trial shows potential to simplify treatment for early syphilis.

Study shows one dose of benzathine penicillin G successfully treated early syphilis just as well as the three-injection regimen. Read more: www.nih.gov/news-events/...

9 Things No One Tells You About Sex After 70 Yes, there's a high likelihood that your parents and grandparents are still having sex.

It's #NationalSeniorCitizenDay today! Read more about how sex changes in your golden years: www.huffpost.com/entry/sex-af...

We Have More PrEP Options Than Ever—But Who Will Be Able To Afford Them? HIV advocates worry the high sticker price for brand-name PrEP—including long-acting injectables—will limit access, especially as federal support wavers.

In June, the U.S. FDA approved the breakthrough HIV prevention drug Yeztugo (lenacapavir), which requires just two shots annually. However, questions loom about whether enough people who could benefit from the drug will take it. Read more: www.thebody.com/news/hiv/mor...

Partnership to End HIV, STD, and Hepatitis Calls For Immediate Release of Ryan White Part F Funding WASHINGTON, DC, UNITED STATES, August 8, 2025 / EINPresswire.com / -- The Partnership to End HIV, STDs, and Hepatitis is deeply concerned about recent reports that the Trump Administration is planning...

The Partnership to End HIV, STD, and Hepatitis calls for immediate release of Ryan White Part F funding. Read more: apnews.com/press-releas...

ID Experts Pan Trump Order Calling for Forced Hospitalization of Homeless People Another example of 'throwing out a policy without input from experts,' says HIVMA chair

"Anytime you're throwing a threat into the mix that someone's freedom could be harmed, it's going to make people shut down; they're not going to show up for healthcare services," Elizabeth Finley of NCSD told MedPage Today. Read more: www.medpagetoday.com/infectiousdi...

Susan Monarez confirmed as Trump's CDC director The Senate on Tuesday confirmed Susan Monarez to be President Trump’s director of the Centers for Disease Control and Prevention.

The Senate on Tuesday confirmed Susan Monarez to be President Donald Trump’s director of the U.S. Centers for Disease Control and Prevention. Read more: www.statnews.com/2025/07/29/s...

US Drafts Plan To Change PEPFAR's Focus From HIV To Diseases That Could Threaten Americans - Health Policy Watch US State Department officials are developing a plan to transform the President’s Emergency Plan for AIDS Relief (PEPFAR) from an entity that tackles HIV to

US State Department officials are developing a plan to transform the President’s Emergency Plan for AIDS Relief (PEPFAR) from an entity that tackles HIV to one that is broadly focused on protecting and promoting American interests. Read more: healthpolicy-watch.news/us-officials...

A new recall of injected penicillin may put gains against syphilis in peril | CNN Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the antibiotic penicillin, the preferred option for treating syphilis during preg...

Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, following a July 10 recall of certain lots of Bicillin L-A that were found to be contaminated with floating particles. Read more: www.cnn.com/2025/07/16/h...

Senate passes Trump’s tax-cut bill that would slash Medicaid spending The Senate has passed a $4.5 trillion tax cut bill after last-minute changes to its health care provisions, as Republicans scrambled to get their party on board.

#Breaking: The Senate passed a $4.5 trillion tax cut bill after last-minute changes to its health care provisions, as Republicans scrambled to get their party on board.
www.statnews.com/2025/07/01/s...

FDA Approves Twice-Yearly Lenacapavir for HIV Prevention More than 99% of people who received Yeztugo in two large clinical trials remained HIV negative.

The FDA approved twice-yearly lenacapavir (Yeztugo) for PrEP, making it the longest-acting HIV prevention method. Advocates lauded the eagerly awaited approval but expressed concern that the $28,000 annual price tag could limit access as HIV prevention funding is being slashed in the US & worldwide.

HIV protection with just two shots a year: FDA approves Gilead drug A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the current political climate.

The Food and Drug Administration approved Wednesday a powerful new drug that provides nearly complete protection against HIV infection with just a single administration every six months. Read more: www.statnews.com/2025/06/18/f...

CDC workers fired from prominent STI, hepatitis labs are rehired The staff of two world-class CDC laboratories that were slated to be closed by the Trump administration have been informed that their terminations have been canceled.

The staff of two world-class laboratories at the Centers for Disease Control and Prevention that were slated to be closed in a round of cuts announced in April have been informed that their terminations have been canceled. Read more: www.statnews.com/2025/06/16/c...

Closed CDC lab was cornerstone of national, global STI science The Trump administration closed a CDC lab that tracked STIs, including drug-resistant gonorrhea. Experts have painted a grim picture of STI surveillance in the wake of the lab's closing.

“This lab is critical to America’s public health, and the health and livelihood of Americans will be worse off without it,” David C. Harvey, MSW, executive director of the National Coalition of STD Directors, told Healio. Read more: www.healio.com/news/infecti...

Congenital syphilis is on the rise in Arizona. But RFK Jr. didn't mention it in kids health report Congenital syphilis occurs when a pregnant woman with the sexually-transmitted disease passes the infection to her baby in the womb. Cases are on the rise here in Arizona, and there's a national push ...

David C. Harvey, Executive Director of NCSD, talks congenital syphilis during STI Engage, our annual conference, held in Phoenix this year. Read more: www.kjzz.org/politics/202...

WHO announces the development of recommendations on doxycycline prophylaxis for the prevention of sexually transmitted infections WHO is convening a Guideline Development Group for the development of Clinical guidelines on doxycycline prophylaxis for prevention of sexually transmitted infections. Members of the public and intere...

WHO is convening a Guideline Development Group (GDG) for the development of evidence-based clinical guidelines on doxycycline prophylaxis for prevention of STIs. Read more: www.who.int/news/item/28...